| | LOC130063041, LOC130063042 +687 more | Copy number gain | See cases | |
| | LOC130062978, LOC130062979 +903 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | ABHD17A, ADAMTSL5 +219 more | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number gain | See cases | |
| | LOC130063254, LOC130063255 +810 more | Copy number gain | See cases | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided | |
| | | Deletion (3 prime UTR variant) | LMNB2-related disorder | |
| | | Single nucleotide variant (3 prime UTR variant) | LMNB2-related disorder | |
| | | Single nucleotide variant (missense variant) | not provided | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (synonymous variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | not specified +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Microsatellite (intron variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Microsatellite (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Microsatellite (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Microsatellite (inframe_deletion) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +2 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +2 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | Lipodystrophy, partial, acquired, susceptibility to +2 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +2 more | |
| | | Single nucleotide variant (synonymous variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (synonymous variant) | LMNB2-related disorder | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (intron variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (intron variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +2 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +2 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | LMNB2-related disorder | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | not specified +2 more | |
| | | Single nucleotide variant (synonymous variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +2 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +2 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Deletion (frameshift variant) | Progressive myoclonic epilepsy type 9 +1 more | |
| | | Single nucleotide variant (missense variant) | Lipodystrophy, partial, acquired, susceptibility to +1 more | |